Logo image of ALMU

AELUMA INC (ALMU) Stock Fundamental Analysis

NASDAQ:ALMU - Nasdaq - US00776X1090 - Common Stock - Currency: USD

17.48  -0.28 (-1.58%)

After market: 17.7 +0.22 (+1.26%)

Fundamental Rating

1

Taking everything into account, ALMU scores 1 out of 10 in our fundamental rating. ALMU was compared to 0 industry peers in the Unkown industry. ALMU may be in some trouble as it scores bad on both profitability and health. ALMU does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ALMU had negative earnings in the past year.
In the past year ALMU has reported a negative cash flow from operations.
ALMU Yearly Net Income VS EBIT VS OCF VS FCFALMU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -1M -2M -3M -4M -5M

1.2 Ratios

Industry RankSector Rank
ROA -82.51%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALMU Yearly ROA, ROE, ROICALMU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -1K -2K -3K

1.3 Margins

ALMU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALMU Yearly Profit, Operating, Gross MarginsALMU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

More info and screens

3

2. Health

2.1 Basic Checks

ALMU does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for ALMU. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ALMU Yearly Shares OutstandingALMU Yearly Shares OutstandingYearly Shares Outstanding 2021 2M 4M 6M 8M 10M
ALMU Yearly Total Debt VS Total AssetsALMU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 50K 100K 150K

2.2 Solvency

ALMU has an Altman-Z score of 17.23. This indicates that ALMU is financially healthy and has little risk of bankruptcy at the moment.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 17.23
ROIC/WACCN/A
WACC10.18%
ALMU Yearly LT Debt VS Equity VS FCFALMU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 -1M -2M -3M -4M

2.3 Liquidity

A Current Ratio of 9.27 indicates that ALMU has no problem at all paying its short term obligations.
A Quick Ratio of 9.27 indicates that ALMU has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 9.27
Quick Ratio 9.27
ALMU Yearly Current Assets VS Current LiabilitesALMU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 50K 100K

More info and screens

1

3. Growth

3.1 Past

ALMU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.51%, which is quite impressive.
ALMU shows a strong growth in Revenue. In the last year, the Revenue has grown by 375.22%.
EPS 1Y (TTM)21.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-155.39%
Revenue 1Y (TTM)375.22%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%513.12%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALMU Yearly Revenue VS EstimatesALMU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 200K 400K 600K 800K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALMU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALMU Price Earnings VS Forward Price EarningsALMU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALMU Per share dataALMU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALMU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AELUMA INC

NASDAQ:ALMU (7/22/2025, 8:00:00 PM)

After market: 17.7 +0.22 (+1.26%)

17.48

-0.28 (-1.58%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners5.51%
Inst Owner Change0%
Ins Owners31.54%
Ins Owner Change5.98%
Market Cap270.07M
AnalystsN/A
Price TargetN/A
Short Float %7.12%
Short Ratio1.84
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 99.42
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.46
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS0.18
BVpS-0.07
TBVpS-0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -82.51%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.7%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 51.95%
Cap/Sales 7.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.27
Quick Ratio 9.27
Altman-Z 17.23
F-Score5
WACC10.18%
ROIC/WACCN/A
Cap/Depr(3y)464.83%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-155.39%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)375.22%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%513.12%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y12.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y5.04%
OCF growth 3YN/A
OCF growth 5YN/A